MEDICA 16 is primarily utilized in research settings to study lipid metabolism and its related disorders. It functions as an inhibitor of acetyl-CoA carboxylase, an enzyme crucial for fatty acid synthesis. By blocking this enzyme, it helps researchers understand the regulation of lipid production and its impact on conditions like obesity, diabetes, and cardiovascular diseases. Additionally, MEDICA 16 has been explored for its potential anti-cancer properties, particularly in inhibiting the growth of certain cancer cells that rely heavily on lipid synthesis for proliferation. Its role in modulating metabolic pathways makes it a valuable tool in both biochemical research and therapeutic development.